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Summary
Objective: Clinical cartilage repair with transplantation of cultured chondrocytes, the ﬁrst described technique introduced in 1994, includes
a periosteal membrane but today cells are also implanted without the periosteal combination. The aim of this study was to see if the
periosteum had more than a biomechanical function and if the periosteum had a biological effect on the seeded cells tested in an agarose
system in which the clonal growth in agarose and the external growth stimulation could be analysed.
Methods: Four different experiments were used to study the growth of human chondrocytes in agarose and the periosteal inﬂuence. Human
chondrocytes were isolated and transferred to either primary or secondary agarose culture. After 4 weeks, the total number of clonesO 50 mm
was counted. Cocultures of chondrocytes and periosteal tissue, cultures of chondrocytes with conditioned medium from chondrocytes,
periosteal cells and ﬁbroblast were used to study a potential stimulatory effect on growth and different cytokines and growth factors were
analysed.
Results: It was found that the human chondrocytes had different growth properties in agarose with the formation of four different types of
clones: a homogenous clone without matrix production, a homogenous clone with matrix production, a differentiated clone with matrix
production and ﬁnally a differentiated clone without matrix production.
The periosteum exerted a paracrine effect on cultured chondrocytes in agarose resulting in a higher degree of cloning. The chondrocytes
produced signiﬁcant amounts of interleukin (IL)-6, IL-8, granulocyteemacrophage colony-stimulating factor (GM-CSF) and transforming
growth factor (TGF)-b. The periosteum produced signiﬁcant amounts of IL-6, IL-8 and TGF-b. Cocultures of chondrocytes and periosteum
demonstrated a potentiation of IL-6 and IL-8 release but not of TGF-b and GM-CSF.
Conclusion: Articular chondrocytes are able to form clones of different properties in agarose and the periosteum has a capacity of stimulating
chondrocyte clonal growth and differentiation and secretes signiﬁcant amounts of IL-6, IL-8, GM-CSF and TGF-b. It may be that the repair of
cartilage defects with seeded chondrocytes could beneﬁt from the combination with a periosteal graft. The production of TGF-b by implanted
chondrocytes could inﬂuence the chondrogenic cells in the periosteum to start a periosteal chondrogenesis and together with the matrix from
implanted chondrocyte production, a repair of cartilaginous appearance may develop; a dual chondrogenic response is possible.
ª 2004 OsteoArthritis Research Society International. Published by Elsevier Ltd. All rights reserved.





The capacity of periosteum to form a hyaline-like repair
tissue when used as a free autologous graft for osteochon-
dral defects in rabbits and humans is well documented1e5.
In most experimental studies, young or adolescent animals
have been used and the periosteal graft has been
combined with an opening of the bone marrow cavity3e7.
The repair tissue formed in these studies has been claimed
to originate from the periosteum3,7. However, Vachon et al.8
used periosteal autografts for the repair of large osteochon-
dral defects in adult horses and found that the biochemical
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Received 13 February 2004; revision accepted 22 October 2004.14composition of the repair tissue of grafted and non-grafted
defects was similar, but clearly differed from that of normal
articular cartilage.
Both experimentally and in clinical cartilage repair,
a technique has been used in which cultured autologous
chondrocytes are transplanted into full-thickness cartilage
defects covered with a free periosteal ﬂap without a con-
comitant opening of the subchondral bone9. The primary
function of the periosteal ﬂap is thus as a mechanical barrier
that minimizes leakage of seeded chondrocytes. The
control defects that had been treated with periosteal graft
but without chondrocytes showed a signiﬁcantly lower
degree of healing compared to the cell transplanted sides.
Defects that had been treated by periosteum alone showed
a healing rate comparable to the intrinsic healing seen in
defects with no treatment at all, which implies that the
periosteal cells alone did not contribute signiﬁcantly to the
healing process. Autologous chondrocyte transplantation6
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biopsies showed a hyaline-like cartilage repair tissue. Since
a periosteal free graft is used to cover the cell transplanted
defect, we wanted to study if periosteum had a functional
role exceeding the basic function as a mechanical cover.
In vivo, cells interact via a signalling system and what
growth stimulating factors in a cascade that are needed to
totally control the chondrocytes are not known even though
there is a knowledge about separate cytokines and growth
factors inﬂuencing the chondrocytes. However, it is well
known that different tissues produce different amounts of
signalling factors that could be studied in tissue coculture
systems and/or with conditioned medium from the different
tissues We looked upon a certain number of potential
inﬂuencing growth stimulatory factors that were available at
our laboratory.
In order to study the periosteal effect on chondrocytes, an
agarose system was set up to study the effects on the
morphology, growth and proliferation of chondrocyte and
the eventual paracrine loop between the tissue and the cells
studied.
The aim of the present investigation was to study the
clonal growth capacity of articular chondrocytes in agarose
and to study if any periosteal inﬂuence on the clonal
chondrocyte growth could be found.
Our hypothesis was that chondrocytes isolated from adult
human cartilage might beneﬁt from a periosteal tissue
exerting a paracrine effect on the cells cultured in the
agarose. Such an interaction could indicate that the peri-
osteal tissue could have a critical functional role in cartilage
repair inducedwith transplanted chondrocytes in suspension
and with the periosteum as a covering membrane.
Material and methods
During knee reconstruction procedures for patellar
malalignment, cartilage was harvested from patients of
different ages from the medial side of the lateral femoral
condyle neighbouring the fossa intercondylea or from
patients undergoing chondrocyte transplantation. The peri-
osteum was removed from the upper medial side of the
tibia. The ethics committee of the Medical Faculty,
Go¨teborg University, approved this study.
ISOLATION OF CHONDROCYTES FROM
CARTILAGE BIOPSIES
The cartilage biopsies were transported to the cell culture
laboratory in sterile 0.9% sodium chloride. The biopsies
were minced and washed twice in Ham’s F-12 medium
(Gibco-BRL, Paisley, Scotland) and supplemented with
gentamicin sulphate (50 mg/ml). The minced cartilage was
digested overnight (16e20 h) in a 25 cm2 culture ﬂask
(Costar, Cambridge, MA, USA) containing 5 ml of Ham’s
F-12 medium supplemented as above, clostridial collage-
nase (0.8 mg/ml, No: C9407, O1200 IU/mg, Sigma, Free-
hold, NJ, USA) and deoxyribonuclease (DNAse) I (0.1 mg/
ml, No: D-5025, Sigma). The isolated cells were washed in
Ham’s F-12 medium and once resuspended in Dulbecco’s
Modiﬁed Eagle’s Medium (DMEM)/F-12 culture medium
supplemented with gentamicin sulphate (50 mg/ml), ampho-
tericin B (2 mg/ml), ascorbic acid (50 mg/ml), L-glutamine
(Gibco-BRL) and 10% foetal calf serum (FCS) (Harlan,
Sera-Lab LTD. Crawley Down, Sussex, England). The
numbers of cells were counted in a haemacytometer.EXPERIMENT I
Specimens from 27 patients (age range 16e53 years)
were used. The chondrocytes were isolated as described
above and transferred to either primary or secondary
agarose cultures.
Primary agarose culture
The primary isolated chondrocytes were suspended in
Ham’s F-12 medium to a cell density of 5! 105 cells/dishes
(primary culture). The cell suspension was mixed with an
equal volume of 2% low gel temperature (LGT) agarose
(Cat no: 162-0020 Bio Rad Laboratories, Richmond, CA
94804) to a ﬁnal cell concentration of 25,000 cells/ml (LGT
cell solution). Cultured dishes (60 mm diameter) were
precoated with 1% of standard low gel (SLG) (Cat no:
162-0100 Bio Rad Laboratories, Hercules, CA 94547) and
2 ml of the LGT cell solution was added to each dish. A 3 ml
volume of feeder medium (DMEM/F-12 (1:1) with addition of
10% serum) was added on top of the agarose cell layer and
the medium was changed once weekly.
Secondary agarose cultures
The primary isolated chondrocytes were ﬁrst cultured in
25 or 75 cm2 culture ﬂasks (Costar, Cambridge, MA, USA)
with DMEM/F-12 (1:1) medium supplemented as above.
After 14e20 days of culturing, 5! 105 cells were isolated
and cultured in agarose as described above for primary
agarose cultures.
After 4 weeks of culturing, the clonal growth of the chon-
drocytes was measured. The total number of clonesO 50 mm
was counted.
EXPERIMENT II
In coculture experiments with periosteum, chondrocytes
from 12 patients with a mean age of 36 (23e82) years and
of different sex were studied. The cartilage specimens were
digested in a spinner bottle at 37(C for 6 h by collagenase
(1 mg/ml Boehringer Mannheim, Mannheim, Germany),
DNAse (0.1 mg/ml, Sigma, Freeholdt, NJ, USA) and
dissolved in 10 ml of Ham’s F-12 medium. After digestion,
the cells were ﬁltered through a nylon mesh and washed
three times in the serum-free medium, counted in a haemo-
cytometer and ﬁnally the cells were suspended in DMEM
with 10% FCS at a cell density of 40,000 cells/ml. The cell
suspension was mixed with an equal volume of 1% LGT
agarose diluted in 2! Ham’s F-12 medium. The mixture
resulted in a ﬁnal cell concentration of 20,000 cells/ml
suspended in DMEM/F-12 (1:1) with 5% FCS and 0.5%
LGT agarose (LGT cell suspension). Five millilitres of the
LGT cell suspension was added to 25 cm2 ﬂasks with 2 mm
grids in the bottoms of the ﬂasks (Costar, Cambridge, MA,
USA) precoated with 2% SLG agarose. The culture protocol
is modiﬁed from Lindahl et al.11. For each patient, two ﬂasks
with chondrocytes were used: one with cells only and one
with an addition of the autologous periosteum (weight 450
(range 330e540) mg) to the gel. The agarose cell
suspensions with or without periosteum were solidiﬁed in
4(C for 10 min and screened for adherent cell clusters of
more than three cells. No such clusters were seen at the
start of the experiment. DMEM/F-12 and 5% FCS were
added on top of the solidiﬁed agarose and culture ﬂasks
were maintained erect for 21 days at 37(C in air containing
5% CO2. After 21 days, the numbers of clones were
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scope. The numbers of clones/four grids were counted
throughout the gel thickness representing approximately
5% of the total gel.
EXPERIMENT III
To study the effect of conditioned media on clonal growth,
dermal tissue, periosteum and cartilage were harvested
from six patients with mean age 33 (23e38) years
undergoing knee surgery. The isolation of chondrocytes
was done as described above. The dermal tissue and
periosteal biopsy were cut into pieces in 25 cm2 tissue
culture ﬂasks (Costar, Cambridge, MA, USA) with DMEM/F-
12 (1:1) medium supplemented with 10% FCS until cells
had migrated out from the pieces. When the cells reached
90e100% conﬂuence, the supplement was changed to 5%
FCS and the medium was collected and frozen every week.
Conditioned medium from the periosteal tissue (weight
550 mgG 10%) and from chondrocytes was also collected
and used for the study.
The isolated chondrocytes were diluted in Ham’s F-12
medium at a cell density of 40,000 cells/ml. The cell
suspension was mixed with an equal volume of 2% LGT
agarose (Cat no: 162-0020 Bio Rad Laboratories, Rich-
mond, CA 94804) resulting in a ﬁnal cell concentration of
20,000 cells/ml suspended in DMEM/F-12 (1:1) with 5%
FCS and 0.5% LGT agarose (LGT cell solution). Cultured
dishes (60 mm diameter) were precoated with 1% of SLG
(Cat no: 162-0100 Bio Rad laboratories, Hercules, CA
94547) and 2 ml of LGT cell solution was added to each dish.
A total number of eight Petri dishes with chondrocytes
were made for each patient. Four different conditioned
medium from ﬁbroblast cells, periosteal tissue, periosteal
cells and chondrocytes were diluted 1:1 in DMEM/F-12
supplemented with 5% FCS and 3 ml was added to the
dishes (2 dishes/medium). The agarose cultures were
incubated in 37(C with 7% CO2 and the medium was
changed once a week. After 7 weeks, the number and the
type of chondrocyte clones in the agarose were calculated.
EXPERIMENT IV
Measurements of cytokine and growth factor release
were performed with the following methods.
Primary isolated chondrocytes were seeded in the culture
medium supplemented with 10% autologous serum and
seeded in 25 cm2 culture ﬂasks (Falcon; Primaria) and
maintained at 37(C, 7% CO2 until conﬂuence. The medium
was changed twice a week. After the chondrocytes reached
conﬂuence, the cells were trypsinized, washed and pelleted
by centrifugation (100! g). The chondrocytes were
counted and viability was determined. Subsequently, the
cells were seeded into 24-well culture plates (Costar, USA)
at a concentration of 10,000 cells/cm2 in the complete
medium supplemented with 10% FCS. Pieces of perios-
teum were washed twice with Ham’s F-12 medium to
remove contaminating cells. Specimens were chopped and
each weighted before coculture with chondrocytes. Minced
periosteum was placed in the culture medium and cultures
were maintained for 48 h in 37(C, 7% CO2.
After 48 h, 400 ml supernatants were removed and
replaced with 400 ml aliquots of the fresh complete medium.
Collected samples of supernatant were centrifuged and
stored at 20(C until they were tested for the presence of
interleukin (IL)-6, IL-8, transforming growth factor(TGF)-b1,granulocyteemacrophage colony-stimulating factor (GM-
CSF).
IL-6 bioassay
The IL-6 dependent murine hybridoma B9 cell line was
used12 to assay IL-6 concentration in supernatants from our
cultures. Before the assays, the B9 cells were washed and
5! 104 cells were seeded per well in ﬂat-bottom 96-well
plate (NUNC, Roskilde, Denmark). Each well was supple-
mented with the sample to be tested. The whole ﬁrst row
with the B9 cells at the 96-well plate was dedicated for the
standard curve and was supplemented with serial dilutions
of recombinant human IL-6 of known concentrations. B9
cells were maintained in an incubator at 37(C with 5% CO2
and water saturated atmosphere for 3 days. At the last 4 h,
1 mCi of (3H) TdR (Amersham) was added to each well and
the cells were harvested onto glass ﬁbre ﬁlters and
unincorporated radioactive thymidine was washed out
carefully. Radioactivity was quantiﬁed in a b-counter.
Measurement of TGF-b1, IL-8, GM-CSF
Enzyme linked the immunosorbent assay (ELISA) kit
Predicta, used for detection of TGF-b1 was bought from
Genzyme Diagnostics. The detection limit of this assay is
50 pg/ml. Assay was carried out according to manual.
Quantiﬁcation of IL-8 and GM-CSF was made by sandwich
ELISA using monoclonal antibodies speciﬁc for detection of
receptive cytokine. GM-CSF antibody was obtained from
Pharmingen (San Diego, USA). IL-8 antibody was bought
from R&D Systems (England). NUNC immunoplates were
used for assays. Sensitivity level for GM-CSF isO60 pg/ml,
and for IL-8 detection limit is 40 pg/ml.
STATISTICAL ANALYSIS
Statistical analysis was performed with one way analysis
of variance (ANOVA) (experiments I and IV), Friedman
ANOVA rank sum test (experiment III) and Wilcoxon’s non-
parametric signed rank test (experiment II). (Program from
STATISTICA, Stat Soft Inc OK, USA.)
Results
EXPERIMENT I
Clonal growth of human chondrocytes
in agarose
The clonal growth of human articular chondrocytes in
suspension cultures stabilized with agarose was tested
after primary isolation.
In addition, after 14 days of monolayer cultures corre-
sponding to the approximately six cell doubling (range
5.5e7.3 from primary seeding) the clonal chondrocyte
growth was retested (secondary culture).
The cultures were studied in phase contrast microscope
and in a majority of the cultures there were four types of cell
growth that could be identiﬁed. Most of the seeded cells
remained as single cells or pair of cells with a majority
surrounded by matrix. Each type of clone was designated
depending on the morphology seen in agarose. The clones
were classiﬁed as homogenous (H) identiﬁed as a spherical
dense mass of cells, homogenous-matrix (Hm) with the
matrix surrounding the cell cluster having a similar size as
the homogenous cluster, differentiated-matrix (Dm) with
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surrounding cells not in contact with each other and ﬁnally
a differentiated clone (D) with few cells and matrix (Fig. 1).
However, because of overlapping similarities between the
Hm cell cluster and Dm cell cluster with both groups having
a homogenous nucleus of cells, these two groups were
subsequently added and counted on as one group of matrix
clones when described in the ﬁgures. The relative
distribution and absolute numbers of clones differed
between individuals but we were unable to clearly separate
age or sex dependence in this study group. No signiﬁcant
difference in clonal ratio was found when comparing
primary isolated chondrocytes (primary culture) with 14
days of monolayer culture (secondary culture) (Fig. 2).
EXPERIMENT II
Effect of periosteum on clonal growth and
cell proliferation
In all patients tested, periosteal tissue was able to
stimulate clonal chondrocyte growth. The predominant
clone type was of the differentiated type even if a few
matrix and homogenous clones were seen. The mean
numbers of chondrocyte clones/four grids in a gel without
periosteum were 29 (5e57) clones and with a mean size of
4 (2e5) chondrocytes within each clone (differentiated
type). The mean number of clones in a gel with periosteum
was 48 (14e101) and mean size 4 (3e5) chondrocytes
(Fig. 3). There was a signiﬁcant difference about the
number of clones between periosteum in the gel vs no
periosteum (PZ 0.0022).
EXPERIMENT III
The chondrocytes were cultured in agarose and medium
was changed once a week with the conditioned medium
sampled after 1 week from either periosteal tissue (550 mg/
25 cm2 ﬂask), conﬂuent cell cultures of periosteal, ﬁbroblast
cells or articular chondrocytes. The effect of the different
conditioned media on clonal growth and clonal category
was evaluated for each individual; a signiﬁcant stimulatory
effect on clonal growth of conditioned medium sampledfrom periosteal tissue or periosteal cell was demonstrated.
However, only a minor effect was demonstrated in the
conditioned medium from ﬁbroblasts or from the chondro-
cyte-conditioned medium (Fig. 4).
EXPERIMENT IV
Cytokine production by chondrocytes,
periosteum
Evaluating potential factors involved in paracrine stimu-
lation of chondrocytes we studied the following cytokines in
the culture medium from periosteum alone, articular
chondrocytes and cocultures of articular chondrocytes and
periosteum: IL-6, IL-8, TGF-b and GM-CSF. We found that
articular chondrocytes produced signiﬁcant amounts of IL-6
and IL-8, GM-CSF and TGF-b. Minced pieces of periosteum
placed in cultured medium and cultured for 48 h produced
signiﬁcant amounts of IL-6, IL-8 and TGF-b. Cocultures of
chondrocytes and periosteum demonstrated a signiﬁcant
increase of IL-6 and IL-8 release but not of TGF-b and GM-
CSF (Table I).
Discussion
In this study, we demonstrate that periosteum is able to
stimulate, articular chondrocytes in a paracrine manner and
that chondrocytes and periosteum have the capacity to
secrete cytokines that could be of potential interest for the
process of cartilage repair. Furthermore, we also found
clonal heterogeneity of primary isolated and secondary
passaged articular chondrocytes cultured in agarose which
indicates a cellular hierarchy within the tissue.
To study the impact of periosteum on cloning efﬁciency
and clone category we used agarose gel suspension
cultures since it is well established that chondrocytes but
not ﬁbroblasts express clonal growth in soft agar suspen-
sion cultures13. We were here able to present an early
description of the clonal growth properties of cultured
chondrocytes in agarose. The clones formed from primary
chondrocyte cultures were heterogeneous in character and
were named homogenous, Homogenous-matrix, differenti-
ated or Differentiated-matrix.Fig. 1. Categorization of clonal growth of human articular chondrocytes in suspension. Chondrocytes were isolated from articular cartilage as
described in Material and Methods. Cells were cultured in suspension cultures stabilized with agarose in DMEM/F-12 (1:1) medium with
addition of 10% FCS. Medium was changed once weekly and photos of clones were taken after 4 weeks of culture. BarZ 100 mm. a)
Homogenous clone, b) Homogenous-matrix clone, c) Differentiated-matrix clone, d) differentiated clone
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discussed, all clones were considered as one type11. We
here postulate that articular chondrocytes have different
growth properties in agarose and we believe that homog-
enous clones without matrix production represent a more
primitive cell type, i.e., a prechondrocyte clone. The matrix
forming clones (Hm and Dm) grew with the simultaneous
production of matrix and could represent more differentiated
cell types although with an intact growth potential. These
two types had such similarities that they sometimes were
Fig. 2. Cloning efﬁciency of homogenous, matrix and differentiated
clones from human articular chondrocytes cultured in suspension
stabilized with agarose. Chondrocytes were isolated from articular
cartilage as described in Material and Methods. Cells were cultured
in suspension cultures stabilized with agarose in DMEM/F-12(1:1)
medium with addition of 10% FCS. Chondrocytes were seeded
either directly after cell isolation (primary) or after second passage
in monolayer cultures (secondary). Medium was changed once
weekly and clones counted and classiﬁed after 4 weeks of cultures.
Counting and categorization were performed under microscope by
two individuals and the mean value was calculated. Data
representing means from 27 patients (age range 16e53 years).
Fig. 3. Effects of conditioned medium on cloning efﬁciency of
human articular chondrocytes cultured in suspension stabilized with
agarose. Chondrocytes were isolated from articular cartilage as
described in Material and Methods. Cells were cultured in
suspension cultures stabilized with agarose in DMEM/F-12 (1:1)
medium with addition of 5% FCS in the absence (A) or presence (B)
of 450 mg periosteum (range 330e540). Medium was changed
once weekly and clones counted and classiﬁed after 4 weeks of
cultures. Counting and categorization were performed under
microscope by two individuals and the mean value calculated.
Data representing means from 12 patients with mean age 36 (range
23e82) years.difﬁcult to subgroup and were subsequently put into one
group of matrix clones. Finally, a fourth type of clones was
found which were unable to further proliferate, thus
indicating a terminally differentiated cell type.
Interestingly, the relative ratio between the clones
remained approximately the same after secondary passage
indicating that monolayer cultures do not alter the growth
potential of progenitor cells for homogenous and matrix
clones. Similar ﬁndings have earlier been demonstrated in
rat epiphysis chondrocytes14.
In 1930, Ham15 was the ﬁrst to report that the cells of the
deep cambium layer in periosteum had chondrogenic as
well as an osteogenic potential, and in 1955, Cohen and
Lacroix were the ﬁrst to propose the periosteum as a graft
material for bone and cartilage repair16. The periosteum of
long bones is derived from perichondrium explaining why
mature periosteal membranes contain chondroblast pro-
genitors. Periosteum from the ileum and scapula provides
the greatest overall chondrogenic capacity17 while perios-
teum derived from skull bones has no chondrogenic
potential. Periosteum from the medial tibia on the other
hand exhibits a marked regional variation of chondrogenic
capacity17. There is now evidence for the hypothesis that
there is a population of mesenchymal stem cells or
progenitor cells present in the periosteum and in the bone
marrow able to support tissue regeneration and/or repair.
Both the progenitor cells of the periosteum as well as the
progenitor cells of the bone marrow can be released up to
a certain age18e20, but there is an age dependent decline in
the osteochondrogenic ability due to an age dependent
decline in number of osteochondral progenitor cells.
It is well established that periosteum forms a hyaline-like
repair tissue when used as free autologous grafts for
cartilage defects in rabbits and humans1e7,21. To what
extent periosteum contributes to the repair tissue is
unknown since the periosteal grafts were mostly used
together with an opening of the subchondral space making
Fig. 4. Effects of conditioned medium from ﬁbroblasts, periosteum,
periosteal cells and chondrocytes on cloning efﬁciency of homog-
enous, matrix (homogenous and differentiated) and differentiated
chondrocyte clones. Human articular chondrocytes were isolated
from articular cartilage as previously described. The chondrocytes
were seeded in suspension cultures stabilized with agarose in
conditioned medium from autologous ﬁbroblasts, periosteum,
periosteal cells and chondrocytes cultured in the same medium.
Values represent the mean values of six patients.
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Cytokine production by articular chondrocytes, periosteum and cocultures of cells and periosteum. Cells at a density of 10,000 cells per cm2 or
periosteal tissue were seeded in 48 wells culture in 3 ml culture medium (DMEM/F-12 (1:1) with 10% FCS). Four hundred microlitres of
aliquots was taken after 48 h for cytokine analysis. Statistical analysis was performed with one way ANOVA comparing the concentration of
cytokines and growth factors in chondrocytes and periosteum alone with the cocultures of chondrocytes and periosteum. Values are
meanG S.E.M., NDZ non-detectable, NAZ non-available, NSZ non-significant. Experiment was repeated three times with similar results.
Cytokine Tissue Concentration (mg/l) mg/10,000 cells or 1 g
periosteal tissue (w/w)
IL-6 Cultured chondrocytes 6.4G 2.2 1.2G 0.4
Periosteum 8.7G 7.0 39.9G 31.4
PeriosteumC chondrocytes 27.1G 3.9, P! 0.05 NA
IL-8 Cultured chondrocytes 1.5G 0.6 0.3G 0.1
Periosteum 2.1G 1.5 9.0G 6.5
PeriosteumC chondrocytes 12.1G 7.5, P! 0.05 NA
TGF-b Cultured chondrocytes 1.51G 0.79 0.29G 0.15
Periosteum 0.42G 0.31 1.67G 1.1
PeriosteumC chondrocytes 1.40G 0.76 NS NA
GM-CSF Cultured chondrocytes 0.23G 0.22 0.02G 0.02
Periosteum ND ND
PeriosteumC chondrocytes 0.01G 0.01 NS NAit possible for chondrogeneic progenitor cells from the bone
marrow to invade the grafted area and to take part in the
repair events.
In recently described studies, a combination of periost
and cultured autologous chondrocytes was used to treat
localized chondral defects9,10,22. The periosteal side aug-
mented with cultured chondrocytes signiﬁcantly improved
the repair of the chondral defect compared to the side with
only periosteal grafting9,10,22. It thus seems that chondro-
cytes had a crucial role in the formation of the repair tissue.
You could argue that the periosteal membrane only
functions as protection against chondrocyte leakage and
could be replaced with an artiﬁcial membrane e.g.,
a polyglycolic acid membrane. However, the results from
the present study demonstrate that the periosteum plays an
important biological role and is able to stimulate growth as
well as differentiation of chondrocytes. Furthermore, it may
be speculated that the repair tissue seen in both humans
and in animal models9,10,22e24 is enhanced or dependent
on paracrine stimulation of the chondrocytes provided by
the periosteum.
We noted a stimulatory effect from the periosteal tissue
as well as the periosteal cell conditioned medium but
interestingly a less stimulatory effect when the chondrocyte-
conditioned medium was used for the chondrocytes. These
ﬁndings indicate that there are interactions between the
chondrocytes themselves and an autocrine pathway to
regulate the cell amounts as well as the late developmental
stages.
In our experiments, the chondrocyte cloning was en-
hanced by the paracrine effect from the periosteum but the
periosteum did not demonstrate any chondrogenic potential
nor did periosteal cells cultured in agarose (data not
shown). This contradicts the results from O’Driscoll
et al.25, who found that periosteal explants cultured in
agarose gels were able to form cartilage due to a change in
the cell microenvironment. The difference could be because
we used human cells in our study and it could differ from the
rabbit cells that were studied by O’Driscoll et al.25.We also
did not use TGF-b to stimulate the periosteum as often used
in periosteal chondrogeneic experiments. O’Driscoll et al.25
found a signiﬁcant formation of cartilage, which was
maximum at 6 weeks in the presence of 10 ng of TGF-b1
per ml when rabbit periosteal explants were cultured in
agarose.The paracrine stimulation should not be considered
restricted to stimulation of a single growth factor but should
be seen as a regulatory system depending on the three
compartments: the periosteum, the chondrocytes and/or the
surrounding calciﬁed cartilage and intact cartilage. The
potentiation of IL-6 and IL-8-production in the cocultures
with periosteum and chondrocytes suggests that an
autocrine loop between these two tissues might be involved
in the cartilage repair. Obviously, the cartilage repair tissue
will be dependent on the tuned balance between positive
and negative signals represented by growth factors
secreted from the periosteum, the transplanted chondro-
cytes and the surrounding tissue.
We found that TGF-b was produced by chondrocytes as
well as periosteum and the peptide is an enhancer of the
chondrocyte phenotype of periosteal cells26e28 and it is an
important cytokine29 in initiating and promoting cartilage
formation in vivo30. This ﬁnding also corroborates with the
ﬁndings by Nakase et al.31, who studied the developmental
potential of periosteum-derived cells with clonal assess-
ment in an agar gel culture system. Morphologically, two
types of colonies were predominantly observed. By
immunocytochemical, observation with antibodies against
aggrecan or bone Gla protein, one type of colony was
judged chondrogenic, and the other osteogenic. By
chronological observation, each type of colony did not
convert to the other. Supplementation with TGF-b1 short-
ened the time course of chondrogenesis and increased
colony-forming efﬁciency of chondrogenic colonies. On the
other hand, colony-forming efﬁciency of osteogenic colo-
nies decreased with TGF-b1 treatment whereas the time
course of osteogenesis remained unaffected. These ob-
servations suggest that there are both committed osteo-
progenitor and chondroprogenitor cells present in the
periosteal cell population, and TGF-b1 stimulates pro-
liferation and differentiation of chondrogenic cell population
by its targeted action.
A hypothesis regarding the use of periosteum in
autologous chondrocyte transplantation is that the pro-
duction of TGF-b by implanted chondrocytes may inﬂuence
the chondrogeneic cells in the periosteum to start a perios-
teal chondrogenesis and together with the matrix from
implanted chondrocyte production, a repair of cartilaginous
appearance may develop; a dual chondrogenic response is
possible (Fig. 5).
152 M. Brittberg et al.: Clonal growth and the functional role of the periosteumGM-CSF and IL-6 are released from chondrocytes after
stimulation with IL-1 and are considered as potential
candidates for cartilage resorption in rheumatoid arthri-
tis32,33. In addition, IL-8 release has been demonstrated in
chondrocyte cultures and the cytokine is dependent on IL-
1b stimulation34. However, the levels we found in our
studies are low compared to the induced levels of IL-6, IL-8
and GM-CSF found after IL-1a and IL-1b stimulation and
the functional role of the lower secreted levels remains to be
elucidated.
Osborn et al.35 studied different growth factors, insulin
growth factor-I (IGF-I), insulin, epidermal growth factor,
ﬁbroblast growth factor (FGF), individually as well as in
combination and they exerted an anabolic effect on both
DNA synthesis and sulphated polyglucan synthesis. They
postulated that the chondrocytes possess the capacity for
endocrine stimulation of anabolic activity and that it might
be possible to externally inﬂuence this activity. We here
conclude that the combined use of periosteum and
chondrocytes, a biological composite implant, could be
such external inﬂuence. The signalling effect from chon-
drogeneic cells within a tissue has attracted interest from
many researchers in the last years.
In the chondrocyte expansion aimed for human trans-
plantation, the cells are cultured in FCS or in the patients
own serum while, when the cells are implanted in vivo, the
nutrition comes from the synovial ﬂuid. You may suspect
that there is a cascade of synovial growth promoting factors
that could affect the implanted cells, and the ones that we
have studied are only a small fraction. In a recent paper,
Chaipinyo et al.36 found that a combination of three growth
factors (10 ng/ml TGF-b1C 100 ng/ml IGF-IC 10 ng/ml b-
FGF) added to serum-free culture medium in a chondrocyte
culture system enhanced the mitotic activity of bovine
chondrocytes similar to 20% FCS. However, more in-
formation is needed about the inter-and intracellular
communications that committed chondrocytes and chon-
drogeneic progenitor cells are using to induce and regulate
the repair of cartilage.
Fig. 5. A cartilage defect covered with a periosteal membrane
(green). The implanted chondrocytes could produce TGF-b which
may stimulate chondrogenic cambium cells to switch into chon-
drocytes. The implanted chondrocytes together with chondrocytes
induced cambium cells may produce a repair tissue with
cartilaginous characteristics. Pink round-shaped cells in defect: im-
planted chondrocytes. Elongated blue cells in periosteum: osteo-
genic cambium cells. Elongated red cells in periosteum:
chondrogenic cells in cambium layer, capable of responding to
TGF-b-stimulation. Orange round-shaped cells in defect: perioste-
al-derived chondrocytes. Green elongated cells in periosteum:
ﬁbroblastic cells.The tendency today in both basic and clinical cartilage
repairs is to use implantable chondrocyte-seeded constructs
such as biodegradable membranes functioning as carriers
or pure three-dimensional scaffolds37e40. The aim is to
implant the construct transarthroscopically in an easy way.
These membranes and scaffolds substitute the periosteum
and its biomechanics role. If a biocomposite construct
produced by tissues from both chondrocytes and periosteal
cells is preferable to a repair tissue engineered from only
one cell type, it requires more basic and clinical studies.
In summary, we have found that articular chondrocytes
are able to form clones of different properties in agarose
and that the periosteum has a capacity of stimulating
chondrocyte clonal growth and differentiation and secretes
signiﬁcant amounts of IL-6, IL-8, GM-CSF and TGF-b. The
functional role of the cytokines and growth factors in
induced cartilage repair remains to be elucidated.
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